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Hepatocellular carcinoma (HCC) is the 3rd cause of cancer-related death worldwide. 
Most cases arise in a background of chronic inflammation, extracellular matrix (ECM) 
remodeling, severe fibrosis and stem/progenitor cell amplification. Although HCCs 
are soft cellular tumors, they may contain fibrous nests within the tumor mass. Thus, 
the aim of this study was to explore cancer cell phenotypes in fibrous nests. 
Combined anatomic pathology, tissue microarray and real-time PCR analyses 
revealed that HCCs (n=82) containing fibrous nests were poorly differentiated, 
expressed Wnt pathway components and target genes, as well as markers of 
stem/progenitor cells, such as CD44, LGR5 and SOX9. Consistently, in severe liver 
fibroses (n=66) and in HCCs containing fibrous nests, weighted correlation analysis 
revealed a gene network including the myofibroblast marker ACTA2, the basement 
membrane components COL4A1 and LAMC1, the Wnt pathway members FZD1; 
FZD7; WNT2; LEF1; DKK1 and the Secreted Frizzled Related Proteins (SFRPs) 1; 2 
and 5. Moreover, unbiased random survival forest analysis of a transcriptomic 
dataset of 247 HCC patients revealed high DKK1, COL4A1, SFRP1 and LAMC1 to 
be associated with advanced tumor staging as well as with bad overall and disease-
free survival. In vitro, these genes were upregulated in liver cancer stem/progenitor 
cells upon Wnt-induced mesenchymal commitment and myofibroblast differentiation. 
In conclusion, fibrous nests express Wnt target genes, as well as markers of cancer 
stem cells and mesenchymal commitment. Fibrous nests embody the specific 
microenvironment of the cancer stem cell niche and can be detected by routine 





 Fibrous nests contain myofibroblast activation and cancer stem/progenitor cell 
markers.  
 Cancers carrying fibrous nests express a minimal signature associated with 
advanced tumor stage and bad clinical outcome.  
 Wnt signals induce the minimal “fibrous nest signature” in liver cancer 
stem/progenitor cells in vitro.  
 Wnt signals lead to mesenchymal commitment of liver cancer stem/progenitor 





The incidence of human hepatocellular carcinoma (HCC) has doubled over the past 
20 years and projections anticipate a further increase despite recent breakthroughs 
leading to virological cure of chronic hepatitis(1). More than 80% of HCCs arise in 
fibrotic livers as a result of HCV or HBV infections, alcohol, hemochromatosis, 
metabolic syndrome or genotoxins(2). Recurrent bouts of liver cell damage and 
chronic inflammation result in progressive fibrosis and amplification of the stem cell 
niche(3). Severe liver fibrosis is thus a pre-neoplastic condition at high risk of 
developing HCC(4).  
Molecular analysis of liver tissues in search for stem cells reveals a diversity of 
phenotypes(3) because the cells commonly observed under the microscope are 
“transit-amplifying stem cells”(3). They are the progeny of stem cells that combine 
stem, hepatocyte and biliary cell markers. Some of the current molecular markers 
that help their identification are CD44, which is a hyaluronic acid receptor(5); LGR5, 
which is an R-spondin receptor that amplifies Wnt signaling(6); SOX9, which 
contributes to the Wnt-dependent maintenance of progenitor cells(7, 8) and, like 
EPCAM and KRT19, is expressed by multipotent ductal stem cells in normal liver(3). 
Except for KRT19, all of them are Wnt/β-catenin target genes. This further highlights 
the importance of Wnt signaling in stem cell control(9). EPCAM and KRT19 label 
bipotent progenitor cells with an intermediate phenotype between hepatocytes and 
bile duct cells and identify malignant bile duct cell components in combined 
hepatocellular-cholangiocarcinoma, which is a particularly aggressive form of liver 
cancer(10, 11). Other molecules highlight mesenchyme-committed progenitor cells, 
such as IGFBP5, which is a Wnt/β-catenin pathway target gene involved in 
mesenchymal commitment of stem cells (12). Along these lines, we recently showed 
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that Wnt signals reprogram tumorigenic liver progenitor cells to replicating fibrogenic 
myofibroblast-like cells displaying stem and invasive features and expressing the 
stem cell markers IGFBP5, LEF1, CD44 and LGR5(13).  
The activation of the Wnt/β-catenin pathway involves interaction of Wnt ligands with 
cell surface Frizzled (FZD) receptors and LRP5/6 co-receptors, followed by disruption 
of the Adenomatous polyposis coli (APC)-axin platform, which blocks GSK3B-
dependent phosphorylation of β-catenin. Non-phosphorylated β-catenin is thus 
stabilized, accumulates in the cytoplasm and nucleus and interacts with the family of 
T-cell factor (TCF)/lymphoid enhancer factor (LEF) transcription factors of target 
gene expression. As LEF1 is a β-catenin target gene, it leads to cell autonomous 
pathway activation(14). At the opposite, in the absence of interaction of Wnt ligands 
with their cell surface receptors, phosphorylated β-catenin undergoes proteasomal 
degradation(15).  
Wnt signaling is regulated at the cell surface by extracellular modulators, including 
the Secreted Frizzled Related Protein (SFRPs) and Dickkopf (DKK) families, Wnt 
Inhibitory Factor-1 (WIF-1) and the ZNRF3 and RNF43 transmembrane E3 ubiquitin 
ligases(16). SFRPs are soluble molecules that possess a Frizzled Cysteine-Rich 
Domain (FZD_CRD), structurally homologous to the Wnt-binding domain of the FZD 
receptors(17). They also possess a netrin domain(17). Through their FZD_CRD, not 
only can SFRPs bind Wnts, but also they may directly signal by forming heterodimers 
with the CRD of the FZD receptors(17). Through their netrin domain, they bind 
heparan sulfates(17, 18). SFRPs and SFRP-like proteins are short-range modulators 
of Wnt signals, i.e., secreted at low levels at the cell surface, they exert their effects 
upon nearest-neighbor cells, as we previously showed by co-culture experiments (19, 
20). At low concentrations, SFRPs mask the hydrophobic domains of Wnts, 
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increasing their diffusion at the cell surface, thereby promoting Wnt signaling. At high 
concentration, they block Wnt-FZD receptor interactions(18). Thus, SFRPs may 
either promote or inhibit Wnt signaling depending on concentration, FZD receptor 
context and the composition of the cell surface microenvironment(18). DKKs bind the 
Wnt co-receptors LRP5/6, blocking the formation of ternary LRP-FZD-Wnt complexes 
to inhibit Wnt signaling(16). Last, the transmembrane ubiquitin ligases ZNRF3 and 
RNF43 promote endocytosis and degradation of FZD receptors from the cell surface. 
In turn, these ubiquitin ligases are inhibited by R-spondin binding to LGR5 
receptors(16).  
Among the ECM of components of HCCs, COL4A1 and LAMC1 are major basement 
membrane proteins upregulated in angiogenesis and cancer extracellular matrix 
remodeling(21-23). Of note, LAMC1 expression is modulated by Wnt signaling(24). 
Although HCCs are soft cellular tumors with scant intratumor fibrosis(25), they may 
contain fibrous hotspots within the tumor mass, which we called fibrous nests. The 
aim of this work was to study the cancer cell phenotypes in fibrous nests in HCC. 
Tumors containing fibrous nests revealed a gene expression network composed of 
cancer stem cell markers, cell surface Wnt components and Wnt/β-catenin target 
genes that correlated with myofibroblast and basement membrane markers. 
Unbiased validation of our data in an external 247 HCC patient cohort revealed a 
minimal bad outcome signature in HCCs. This minimal signature was in turn 
upregulated upon reprogramming of liver cancer stem/progenitor cells into fibrogenic, 
myofibroblast-like cells by soluble Wnt ligands in vitro. The findings suggest that a 





Materials and Methods 
Real-time PCR primers and antibodies 
See Supplementary Table 1 for real-time PCR primers and TaqMan probes and 
Supplementary Table 2 for antibodies.  
 
Patients and tissue samples 
Seventy HCC patients undergoing curative liver surgery at Rennes University 
Hospital between January 1992 and December 2007 were included. The microscopic 
features of tumors diagnosed as HCC by staff pathologists were reviewed by a senior 
pathologist (BT). Mixed hepatocellular-cholangiocarcinoma or fibrolamellar HCC were 
excluded. Demographic, clinical and biological data were retrieved from hospital 
charts by two experienced liver surgeons (LS & DB). Eighty-two frozen tumors from 
70 patients were analyzed. Demographical and clinical data are described in 
Supplementary Table 3. We also included 66 matching non-tumor livers, 23 
histologically normal livers and 11 focal nodular hyperplasias. Non-tumor and normal 
liver samples were obtained at >2 cm from the tumors to minimize non-specific 
events, as described(26). Frozen samples were from the Biological Resources 
Center (BRC) at Rennes University Hospital (BB-0033-00056). Fresh tissues were 
frozen at -80°C in N2-cooled isopentane and stored at -80°C under quality-controlled 
conditions. Formalin-fixed, paraffin-embedded tissue blocks were obtained from the 
Anatomic Pathology laboratory. The study protocol complied with French laws and 
regulations and fulfilled the requirements of the local institutional ethics committee. 





Functional Genomics Analyses 
Gene networks were generated by Weighted Correlation Network Analysis (WGCNA, 
WGCNA package)(27) using real-time PCR mRNA expression data from the 
indicated patient groups, after removing the experimental batch effect with the SVA 
package(28). Gene networks were visually integrated with Cytoscape, with a 
correlation coefficient threshold >0.30(29). Genomics analysis using microarray-
based raw gene expression data downloaded from Gene Expression Omnibus were 
background corrected and log2 intensity summary values for each probe set were 
calculated using Robust Multi Array Average (Affy package). Probes were further pre-
filtered using a p-value detection threshold (p<0.05) in all samples. When multiple 
probe sets mapped a unique gene, we used the probe with a p-value detection <0.05 
in most samples. Finally, data were quantile normalized (preprocessCore package) 
and hierarchical clustering was performed with the hclust function in R software, 
applying the Ward method to correlation-based distances. Gene set enrichment 
analysis (GSEA) was performed with the web-based tool developed at the Broad 
Institute (30).  
 
Statistical Analyses 
Raw feature data from Gene Expression Omnibus were background corrected and 
log2 intensity expression summary values for each probe set were calculated using 
the Robust Multiarray Average package (RMA, Affymetrix). Probes were further pre-
filtered using P-value (<5% in all samples). When multiple probe sets mapped a 
unique gene, we used the probe with a p-value detection<0.05 in most samples. For 
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survival analyses, non-tumor and normal tissue samples were excluded from the 
analysis. We then generated a transcriptomic signature associated with disease-free 
survival measured by a Recurrence Index (RI). To this end, we applied the Random 
Survival Forest (RSF) method (RandomForestSRC package). RSF is a method for 
prediction and variable selection for right-censored survival by growing a high 
number of decision trees after bootstrap subsampling(31). A Cumulative hazard 
function (CHF) was calculated for each individual and used to estimate the RI. Input 
variables were the 17 genes analyzed throughout this study. Serum alpha-fetoprotein 
(with a cutoff over 300ng/ml) was also integrated for variable selection. The events to 
predict by RSF were the disease-free survival status at each time. Variable 
importance (VIMP) scores were computed for all the variables used to grow the trees, 
and the most informative from this model were selected to fit a new RSF model. 
Once the model was built, we tested whether selected variables were redundant or 
“noisy” by generating incremental RSF models adding one more variable, ranked by 
the VIMP calculated in the previous model. The final model was used to generate a 
RI score for each individual. RI scores were computed as the sum of the CHF for 
each patient weighted by the number of individuals at risk at distinct time points. 
Survival analyses were performed using the Log Rank test and Kaplan-Meier curves. 
Correlation analyses between gene expression levels were performed with the 
Spearman rank order correlation test (continuous variables, non-parametric 
distribution). Association analyses between binary or ordinal variables (expression 
scores, clinical, biological or anatomic pathology data) were performed with 
Pearson’s Chi2 or Fisher exact test. Group comparisons were done with non-
parametric ANOVA and the Kruskal Wallis post hoc tests, unless otherwise indicated. 
Heatmaps showing associations between binary patient data were constructed with 
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Excel (Microsoft Office 2010). Statistical calculations were performed with the R 
software (version 3.1.1) and the packages survival, colorspace, made4 and marray or 
with Statistica 10 (Statsoft, Maisons-Alfort, France).  
 
For cell culture and clonogenesis assay, nucleic acid extraction, real-time PCR, 
tissue microarray (TMA) and immunohistochemistry scoring of human tissues, see 




3. RESULTS  
3.1. Tumors containing fibrous nests are less differentiated, enriched in Wnt/β-
catenin pathway components and stem/progenitor cell markers  
To study the molecular features of HCCs containing fibrous nests, we reviewed 
archival hematoxylin-eosin-safran-stained tissue sections of 82 HCCs from 70 
patients. We carried out systematic microscopic examination in search for fibrous 
hotspots and we drew a ~1 cm diameter circle around the most fibrotic area on each 
slide. Circled areas were blindly scored for intensity of fibrosis by two observers (BT, 
OM) on a four-point scale (Fig. 1A). Tumor differentiation was assessed by the 
Edmondson’s score on a four-point scale, where score 1 indicates well-differentiated 
tumors and score 4 corresponds to poorly differentiated ones(32). High-grade 
intratumor fibrous hotspots (Fig. 1B) were associated with poor tumor differentiation 
and high expression of the tumor progenitor cell marker mRNAs CD44, IGFBP5, 
SOX9 and LEF1, the soluble modulators of Wnt signals SFRP2 and SFRP5, as well 
as the cell surface anchored heparan sulfate proteoglycan GPC3 (Fig. 1B). Tissue 
microarray-based immunohistochemistry in mirror-image formalin-fixed, paraffin-
embedded sections from the same tumors showed that high-grade intraturmor fibrous 
hotspots contained cancer cell clusters expressing GPC3, CD44, LGR5 and SOX9 
(Figs. 1C and D). By contrast, KRT19 and EPCAM, which label liver progenitor cells 
having an intermediate phenotype between hepatocytes and biliary cells(10, 11), 
were not associated with intratumor fibrosis (Fig. 1B). Fibrous hotspots expressed 
alpha smooth muscle actin (ACTA2), indicating that fibrous nests were enriched in 
myofibroblasts (Fig. 1D).  
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We then studied the relationships between the liver progenitor cell markers KRT19, 
EPCAM, LGR5, SOX9 and GPC3. We chose GPC3 because it is a well-
characterized tumor hepatocyte marker and a cell surface heparan sulfate 
proteoglycan(33, 34) that binds Wnts and FZD receptors, amplifying Wnt signals(34). 
As expected(7, 10), KRT19 was highly correlated with EPCAM (Fig. 2A), and both 
were weakly correlated with SOX9. CD44 was correlated with LGR5, as well as with 
SOX9 and GPC3. Associations between these markers were more easily pinpointed 
by in situ protein analysis of fibrous hotspots, rather than by solution-based mRNA 
analysis of whole frozen tissue blocks. These data are consistent with the notion that 
“fibrous nests” are localized entities, where tumor cells expressing stem/progenitor 
markers may be found at higher densities.  
Then, we split the HCC population in two subsets: low and high tumor fibrosis, using 
a cutoff score ≥2. HCCs with high tumor fibrosis showed higher mRNA and protein 
levels of CD44; GPC3 and SOX9 (Fig. 2, B-D). LEF1 (analyzed at the mRNA level 
only) was also higher in HCCs with high fibrosis scores (Fig. 2E). By contrast, LGR5 
was only associated with high fibrosis scores by immunohistochemistry (Fig. 2F). 
Taken together, these findings suggested that HCCs containing fibrous nests were 
enriched in Wnt/β-catenin pathway target genes and such as CD44, SOX9, LEF1, 
SFRP2 and LGR5 (Fig. 1B, C and 2B, D-F). Some of them are also stem/progenitor 
cell markers, such as CD44, IGFBP5, SOX9 and LGR5 (Fig. 1B, C and 2B, D-F).  
 
3.2. Myofibroblast activation is associated with tumor fibrosis and with the expression 
of cell surface Wnt pathway and basement membrane components.  
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We were surprised to find an association of SFRP2 and 5 with tumor fibrosis 
(Fig. 1B), because SFRPs are frequently downregulated in cancers(35). To confirm 
this finding, we searched for correlations between SFRPs and smooth muscle actin 
(ACTA2), which is a myofibroblast activation marker. High mRNA levels of ACTA2 
were associated with high scores of fibrosis in 78 HCCs (Fig. 3A). In non-tumor 
livers, fibrosis was graded by the METAVIR score(36). Out of 66 available non-tumor 
samples, 62 (92%) showed severe fibrosis, i.e., scores ≥3 (Supplementary Table 3). 
In these samples, SFRP1; 2 and 5 and, in HCCs with high tumor fibrosis, SFRP1 and 
2 correlated with ACTA2 (Fig. 3B). Consistently, Fig. 3C shows that SFRP1; 2 and 5 
were higher in HCCs expressing high ACTA2 levels. We thus asked whether other 
Wnt pathway components were associated with myofibroblast activation in HCCs. 
High levels of the basement membrane components COL4A1 and LAMC1 were 
associated with ACTA2. In addition, DKK1; FZD1; FZD7; WNT2 and LEF1 were 
increased in HCCs expressing high ACTA2 levels. By contrast, WNT3; KRT19 and 
EPCAM were not associated with ACTA2. Taken together, these data suggest that 
myofibroblast activation is associated with the expression of cell surface Wnt 
pathway components.  
 
3.3. SFRP1; 2 and 5 are expressed by mesenchyme-committed cancer 
stem/progenitor cells.  
Cancer-associated myofibroblast-like cells may either originate from stromal cell 
recruitment or from cancer cell dedifferentiation and epithelial-mesenchymal 
transition (EMT)(37, 38). We thus asked whether SFRP expression was a general 
theme in mesenchymal lineage commitment. To achieve a general overview, we 
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studied five cellular models involving mesenchymal commitment and/or myofibroblast 
differentiation. First, we analyzed the GSE49910 microarray dataset gathering 745 
primary cell samples(39). To identify the cell lineages expressing the highest levels of 
SFRPs, we set the cutoff at >0.91 centile for SFRPs 1 and 2 and >0.5 centile for 
SFRP5 (Fig. 4A and Supplementary Fig. 1A). Consistently with our in vivo findings, 
SFRP1 was mainly expressed by smooth muscle cells, stem cell-derived neural 
precursors, stem cells, Schwann cells and fibroblasts (Fig. 4A). SFRP2 was mainly 
expressed by stem cells and NCAM(+)/EPCAM(+) mesodermal progenitors (Fig. 4A), 
which represent the first stages of mesoderm commitment of undifferentiated human 
embryonic stem cells(40). In turn, SFRP5 (Supplementary Fig. 1A) was 
predominantly expressed by cells of mesodermal origin, except for Schwann cells 
and keratinocytes (ectodermal origin). Particularly, the highest levels of SFRP5 were 
detected in mesenchymal stromal cells undergoing osteoblast differentiation.  
Second, a convenient model to study cell plasticity is the generation of hepatocyte-
like cells from fibroblast-derived undifferentiated iPS cells(41) (Fig. 4B). In this model, 
SFRP1 and 2 were preferentially expressed by undifferentiated iPS cells, their 
expression dramatically decreasing upon hepatocyte differentiation (Fig. 4B). By 
contrast, SFRP5 was detected at low levels in fibroblast-derived undifferentiated iPS 
cells (Supplementary Fig. 1B).  
Third, we recently showed that soluble Wnt signals reprogram liver progenitor cells to 
replicating fibrogenic myofibroblast-like cells with stem and invasive features(13). 
Consistently, we confirm here that reprogramming liver progenitors with 200 ng/ml 
Wnt3a induces a dramatic fall in albumin expression by hepatocyte-like cells, shifting 
the cell phenotype toward myofibroblast-like cells expressing ACTA2, COL4A1, 
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LAMC1 (Fig. 4C), as well as SFRP1 and DKK1, with a considerable decrease in the 
epithelial cell marker E-cadherin (Fig. 4D).  
Fourth, cancer cells can dedifferentiate to stem/progenitor cells through transient 
EMT, which fosters tissue invasion, cell proliferation and tumor aggressiveness(38). 
To study the involvement of SFRPs in this process, we used HepaRG progenitor 
cells(38, 42), which are derived from a human HCC(43). Like 60% HCCs, they 
contain a TERT mutation(44), can be tumorigenic in mice(45), but have wild-type β-
catenin pathway components(42). HepaRG progenitor cells differentiate into 
hepatocyte-like and biliary-like cells when grown at confluency for 30 days(42). When 
these differentiated HepaRG cells are split and seeded at low density, they express 
TWIST1 and SNAI1 transcription factors, undergo EMT, dedifferentiate to liver 
progenitors displaying mesenchymal features (fusiform morphology, expression of 
mesenchymal markers such as vimentin and ECM proteins) and express an mRNA 
signature of high tumor aggressiveness four days after seeding (38). Thus, four days 
after seeding differentiated HepaGR cells at low density, we observed high 
expression of SFRP1 and 2, which gradually decreased over 30 days, along 
mesenchymal to epithelial transition (MET) and hepatocyte differentiation (Fig. 5A). 
Of note, SFRP5 was expressed at very low levels in HepaRG cells (Supplementary 
Fig. 3B) and not modulated along hepatocyte differentiation (not shown). SFRP1 and 
2 expression kinetics matched those of LGR5(6) and the fibroblast marker COL1A1 
(Fig. 5A). It was opposite to the kinetics of the hepatocyte differentiation marker 
ALDOB (Fig. 5A). These data indicate that SFRP1 and 2 are upregulated during 
EMT. Conversely, their expression falls during MET in liver cancer cells.  
Fifth, to further explore cell plasticity, we used the 3P/3SP model of spontaneous 
EMT in human HCC(46). Both cell lines derive from the same HCC, 3SP resulting 
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from 3P cells that underwent spontaneous EMT(46). Thus, using publically available 
transcriptomic data from 3P and 3SP cell lines, we found that the genes associated 
with fibrous nests and/or myofibroblast activation were expressed at higher levels in 
mesenchymal 3SP than in epithelial 3P cells (Fig. 5B). Of note, epithelial 3P cells 
expressed higher levels of the tumor hepatocyte marker GPC3(33) and the epithelial 
stem cell marker LGR5(6) than 3SP cells. In addition, although GPC3 and LGR5 
were associated with fibrous nests in HCCs, they were not associated with high 
ACTA2 expression. This is explained by the topography of LGR5 and GPC3 
expressing cells. As shown in Fig. 1D, LGR5 and GPC3 were expressed by nodules 
of epithelial tumor cells. Moreover, we have previously shown that LGR5-expressing 
cells are seen both in epithelial tumor nodules and as single rows of cancer cells 
invading the tumor stroma, in an “Indian file” pattern, interspersed along the axis of 
ECM fibers(13). Further confirming our findings in HCCs, unbiased Gene Set 
Enrichment Analysis (GSEA) revealed that the top 20% of mRNA signatures 
matching the transcriptome of mesenchymal 3SP cells included Wnt/β-catenin 
signaling, stem cells, extracellular matrix remodeling, TGFB signaling, bad outcome 
in cancer and resistance to anti-cancer treatments. Importantly, these stem cell 
signatures matched those of aggressive non-hepatic cancers, indicating that 
mesenchyme-committed liver cancer cells are highly undifferentiated (Fig. 5C and 
Supplementary Table 4).  
 
3.4. Cell surface Wnt pathway components network with the myofibroblast activation 
marker alpha smooth muscle actin (ACTA2) and with the basement membrane 
components collagen type IV (COL4A1) and laminin ɣ1 (LAMC1) in severe liver 
fibrosis and in HCCs with high tumor fibrosis.  
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SFRPs are soluble tissue morphogens that bind the cell surface matrix, thus creating 
short range concentration gradients spanning only a few cells(35). In normal liver, 
SFRPs 1 to 5 mRNAs were expressed at low levels (Supplementary Fig. 2). In eight 
HCC and two colorectal cancer cell lines, SFRP1 and 5 were dramatically lower than 
in normal liver (Supplementary Fig. 3, A and B) and restoring SFRP1 and SFRP5 in 
the Huh-7 HCC cell line decreased clonogenesis (Supplementary Fig. 3, C and D). 
The Huh-7 cell line carries wild-type Wnt/β-catenin pathway components(47), but 
shows active β-catenin as a result of an increase in Wnt ligands and SFRP promoter 
methylation(48, 49). Likewise, we(19, 20, 50) and others(51) have shown that SFRP1 
blocks Wnt/β-catenin signaling and tumor growth in cells carrying β-catenin exon 3 
mutations, including the hepatoblastoma cell line HepG2(50).  
The increase in SFRPs 1; 2 and 5 in HCCs showing myofibroblast activation was 
difficult to reconcile with the dramatic downregulation of SFRPs in cancers(35). To 
understand this paradox, we analyzed 82 HCCs, 66 matching non-tumor livers, 23 
histologically normal liver controls and 11 focal nodular hyperplasias (FNH). FNHs 
are benign liver tumors that display features of the stem cell niche, particularly rich in 
transit-amplifying liver cell progenitors and extracellular matrix remodeling, without 
the potential for tissue destruction of cancer(3, 52).  
Supplementary Fig. 4 shows mRNA expression analysis confirming downregulation 
of SFRP1(48) and upregulation of WNT3(53) in HCCs. SFRP5 was downregulated 
as well. As SFRPs 1 and 5 were lower by several folds in HCCs than in normal liver 
controls, matching non-tumor livers and FNHs, this downregulation appears to be 
cancer-specific and could help the diagnosis of HCCs. By contrast, WNT3, FZD1 and 
FZD7 were higher in HCCs, non-tumor livers and FNHs than in controls. COL4A1 
was expressed at higher levels in HCCs, non-tumor livers and FNHs than in controls. 
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Supplementary Fig. 5 shows that SFRP2, ACTA2, WNT2 and LAMC1 were not 
significantly different in HCCs from controls or non-tumor samples, but that DKK1 
was expressed at higher levels in HCCs than in controls.. 
Ninety-two percent of non-tumor livers in this series showed high fibrosis (61 
out of 66 with METAVIR score ≥3; Supplementary Table 3). In these samples, 
COL4A1, LAMC1 and ACTA2, were correlated with all the Wnt pathway components 
tested but Wnt3 (Supplementary Table 5A). In 82 HCCs, COL4A1, LAMC1 and 
ACTA2 were correlated with SFRPs 1 and 2. The correlation of ACTA2 with SFRPs 1 
and 2 and of COL4A1 with SFRP1 was only seen in HCCs with high tumor fibrosis. 
We then applied Weighted Correlation Network Analysis(27, 29) that revealed 
associations of ECM remodeling and Wnt pathway components, particularly in liver 
fibrosis and in HCCs with high tumor fibrosis, but not in HCCs with low tumor fibrosis 
(Fig. 6). These data indicate that despite the dramatic decrease in SFRP1 and 
SFRP5 expression in HCCs, these SFRPs (within a low-level expression range), as 
well as other cell surface Wnt pathway components (i.e., WNT2, DKK1, FZD7 or 
FZD1) were associated with the basement membrane components COL4A1 and 
LAMC1 and with the myofibroblast activation marker ACTA2. We have previously 
shown that COL4A1 expression is correlated with the mRNA expression of the ECM 
remodeling enzymes MMP2 and MMP14 and with MMP2 enzymatic activity(54). 
Reanalysis of the available unpublished data from that report involving 47 human 
HCCs confirmed that this was also the case for LAMC1 (Supplementary Table 5B). 
Taken together, these findings suggest that the microenvironment of fibrous nests 
brings together myofibroblast activation, expression of basement membrane 




3.5. A minimal Wnt & extracellular matrix signature is associated with tumor 
recurrence and ominous clinical features in patients with HCC.  
Using the 17 genes analyzed in this study, we applied the unbiased random survival 
forest (RSF) method to generate a minimal signature associated with patient 
outcome. To this end, we analyzed a public dataset including whole genome tumor 
tissue mRNA expression data (GSE14520) and clinical annotations (Supplementary 
Table 6) from 247 patients with HCC treated by surgical resection(55). Serum alpha-
fetoprotein >300 ng/ml was also included in variable selection. The events to predict 
were the disease-free survival status at each time point. The final model yielded four 
variables: DKK1; COL4A1; SFRP1 and LAMC1 and was used to generate a 
recurrence risk index (RI; range, 17-132) for each individual. Using the centile 0.75 of 
this index (RI>62), we split the 247-patient dataset in high and low risk groups. Fig. 7 
shows that the high risk group had lower disease-free and overall survival rates over 
a 5-year follow-up. Clinical features of patients with high RI were: advanced tumor 
staging, HCCs arising at a younger age, high serum alpha fetoprotein levels and high 
incidence of the Metastasis Signature (Fig. 7, C, D and Supplementary Table 7). The 
Metastasis Signature(55) is a 161-gene risk classifier enabling prediction of tumor 
relapse in early-stage HCC patients. Clinical features not associated with high RI are 
shown in Supplementary Table 7. In addition, high mRNA levels of FZD7; COL4A1; 
LAMC1; DKK1; SOX9; GPC3 and LEF1 were associated with clinical features 





We found that tumors containing fibrous nests were less differentiated and expressed 
Wnt pathway components and target genes as well as stem/progenitor cell markers. 
Tissue microarray-based immunohistochemistry analysis of tissue carrots directly 
punched from fibrous nests in formalin-fixed paraffin-embedded HCC tissues 
revealed GPC3 (+) HCC cells expressing the tumor stem/progenitor cell markers 
CD44, LGR5 and SOX9. By contrast, neither KRT19 nor EPCAM were associated 
with fibrous nests, probably because combined hepatocellular-cholangiocarcinomas 
were excluded from our study. Similarly, a previous work found that the association of 
KRT19 with fibrous stroma was cohort-dependent(56). GPC3(34) and LGR5(57) are 
both cell surface enhancers of Wnt signaling. GPC3 is specific of tumor hepatocytes 
and is used in routine diagnosis of HCC, with a 77% sensitivity(33). LGR5 hallmarks 
Wnt-driven amplification of liver progenitors(57). In addition, we found other 
molecules associated with fibrous nests and/or myofibroblast activation, such as 
LAMC1, COL4A1, SFRP1; DKK1; FZDs 1 and 7; WNT2, IGFBP5 and LEF1.  
Downregulation of SFRP expression by promoter methylation is a common theme in 
most human cancers, including HCCs(35, 49, 58). Conversely, ectopic expression of 
SFRP1 (48, 51) and SFRP5 (this work) decreases tumor cell growth. By contrast, a 
recent methylome profiling of 304 HCCs did not confirm SFRP promoter methylation 
among the top-100-ranked probes, the frequency of SFRP5 methylation in HCCs 
being of only 3 %(59). As SFRP1 and 5 were by several folds lower in HCCs than in 
non-tumor livers, other mechanisms of SFRP downregulation in HCC should be 
explored. Whatever the case, two lessons were drawn from our findings. First, in 
contrast with FZDs 1; 7 and WNT3, which were upregulated in both tumor and non-
tumor samples, the fall in SFRPs 1 and 5 was HCC-specific. Second, in HCCs, 
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SFRP1 was associated with myofibroblast activation. We confirmed these findings by 
five different cell biology approaches, including Wnt-induced differentiation of liver 
progenitor cells into fibrogenic myofibroblast-like cells, which upregulated SFRP1 
expression. Consistently, SFRP1 favors amplification of mesenchymal stem cells in 
muscular dystrophy(60) and induces matrix metalloproteinase expression and 
pulmonary fibrosis(61). In addition, direct interaction of SFRP1 with the FZD2 
receptor modulates axon growth, the final output depending on the fibronectin/laminin 
balance in the ECM(17).  
We recently showed that soluble Wnt signals reprogram liver cancer progenitor cells 
into myofibroblast-like cells(13). In this context, we confirmed that Wnt-induced 
myofibroblast-like cells upregulate the expression of DKK1, COL4A1, SFRP1 and 
LAMC1. In 247 HCC patients, these four genes were associated with bad disease-
free and overall outcome as well as with advanced tumor staging, high alpha-
fetoprotein levels and a 161-gene signature predicting tumor relapse. Furthermore, 
seven genes upregulated in fibrous nests and/or in HCCs with myofibroblast 
activation were associated with bad outcome predictors (Supplementary Table 8). 
These included FZD7 and DKK1, which are markers of Wnt/β-catenin activation in 
HCCs(62-64). DKK1 is a Wnt pathway inhibitor, which expression is induced by 
active β-catenin. It is thus involved in a negative feedback loop that controls Wnt 
pathway activation in normal cells(65). However, in some cancer types, high DKK1 
reflects active Wnt/β-catenin signaling(64, 66). Particularly, DKK1 is a diagnostic 
biomarker of HCC(67). In turn, WNT2, which is secreted by fibroblasts, activates Wnt 
signaling and tumor progression in oesophageal cancer(68), and is associated with 
the differentiation of pancreatic stellate cells to myofibroblasts in chronic 
pancreatitis(69). In the liver, WNT2 is secreted by sinusoidal endothelial cells and, 
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like LGR5, contributes to the stem cell niche for hepatocyte regeneration after injury 
(6, 57, 70, 71). Altogether, these findings indicate that tumor fibrous hotspots are 
contingent with upregulated expression of cell surface Wnt components and target 
genes, myofibroblast activation and undifferentiated cancer stem cell markers. These 
elements come together within a specific, topographically defined tumor 
microenvironment that we called fibrous nests. This term conveys the notion of cell 
surface signals nurturing tumor growth and associates the cancer stem cell niche 




Figure legends  
Graphical Abstract: “Fibrous nests”: HCCs containing fibrous nests are enriched 
in Wnt signals, i.e., cell surface Wnt pathway components and target genes. These 
are associated with markers of mesenchymal commitment, stem cells and 
extracellular matrix remodeling, indicating tumor aggressiveness. By random forest 
survival analysis, we show a minimal gene signature (DKK1, COL4A1, LAMC1, 
SFRP1) associated with poor clinical outcome. By in vitro experiments, we confirm 
that Wnt signals induce the expression of this minimal gene signature, as well as 
mesenchymal commitment of liver cancer stem/progenitor cells.  
 
Fig. 1. Tumors containing fibrous nests are less differentiated, enriched in 
Wnt/β-catenin pathway components and stem/progenitor cell markers: (A) 
Hematoxylin-eosin-safran staining of formalin-fixed paraffin-embedded HCCs 
showing different grades of tumor fibrosis (TFi). Grade 0, no fibrosis; 1, mild fibrosis 
(i.e., slender fibrous strands in an otherwise sinusoidal stroma, arrows); 2, moderate 
fibrosis (i.e., compact fibrous tissue forming incomplete septa, arrows); 3, severe 
fibrosis (tumor cell clusters completely trapped within dense bridging fibrous tissue). 
(B and C) Data from 82 human HCCs. Tissues were collected and processed to 
create mirror image frozen (B, FROZEN) and formalin-fixed, paraffin-embedded (C, 
PARAFFIN) blocks. Each column corresponds to a tumor. Rows: TFi in 82 human 
HCCs (Low, 0-1; n=43; High, 2-3; n=34), Edmondson-Steiner’s score (Low, 1-2; 
High, 3-4), real-time PCR mRNA expression analysis (qPCR), immunochemistry 
scoring (IHC) on contiguous FROZEN sections and tissue microarray-based IHC on 
PARAFFIN sections. White cells, missing data. P, Fisher’s exact test and Gamma 
correlation coefficient (R=) are shown on the right. (D) TMA-based 
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immunohistochemistry in HCC tissues punched from fibrous hotspots. Peroxidase-
labelled antibodies (brown); hematoxylin counter-staining (blue). Upper left corners, 
gene symbols. Lower left corners, TFi scores. Lower right corners, magnification. 
Tissue slides were scanned at 20X. T, tumor; TFi, tumor fibrosis. Red arrowheads 
indicate isolated CD44, GPC3 or SOX9-staining cells within the tumor stroma. SOX9 
(+) tumor cell clusters are embedded within the fibrous tissue, some of them lying 
within the subendothelial zone of capillary vessels (V, red arrowheads). LGR5 (+) 
tumor cords are interspersed within a loose fibrovascular stroma.  
 
Fig. 2. High expression of cancer stem/progenitor markers in HCCs with tumor 
fibrosis: (A) Spearman’s correlation coefficients between the indicated proteins 
(TMA, Tissue MicroArray-based immunohistochemistry detection) and mRNAs 
(QPCR). Asterisks denote statistical significance *, p<0.05; **, p<0.01; ***, p<0.001. 
The number of analyzed samples is indicated between parentheses. (B-E) Tumor 
fibrosis is associated with high CD44, GPC3, SOX9 (mRNA and protein), LGR5 
(protein) and LEF1 (mRNA) levels. Mean±confidence intervals. P, Mann-Whitney U 
test.  
 
Fig. 3. Myofibroblast activation is associated with tumor fibrosis and with the 
expression of cell surface Wnt pathway and basement membrane components. 
(A) High ACTA2 mRNA levels in tumors with high fibrosis scoring. (B) Spearman’s 
correlation analysis of SFRP1; 2 and 5 with ACTA2 mRNA levels in fibrotic non-tumor 
livers and in HCCs with High and Low Tumor Fibrosis (High TFi; Low TFi). 
Statistically significant correlations are highlighted in red. (C) ACTA2 mRNA levels in 
HCCs were split into High (n=20) and Low (n=58) groups (cutoff = median). SFRP1; 
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2 and 5; the extracellular matrix components COL4A1 and LAMC1; the Wnt inhibitor 
DKK1; the Wnt cell surface receptors FZD1 and FZD7; the WNT2 ligand, the 
mesenchymal cell marker IGFBP5 and the β-catenin pathway transcription factor 
LEF1 are associated with high levels of ACTA2 expression.  
 
Fig. 4. SFRP1 is expressed by mesenchyme-committed cancer stem/progenitor 
cells. (A) SFRP1 and SFRP2 mRNA expression data extracted from the GSE49910 
microarray meta-analysis dataset consisting of 745 primary cell samples analyzed 
with Affymetrix Human Genome U133 Plus 2.0 expression arrays. Normalized 
background-corrected intensities(39) of mRNA expression were filtered to reveal the 
cell lines expressing the highest (>20xmedian; >centile 0.91) mRNA levels of SFRPs 
1 and 2 in at least duplicate samples. Cell lines below the defined threshold but 
originally used as controls of at least one cell line showing >20x median mRNA 
levels, were included for comparative purposes. Threshold lines for each gene are 
indicated (-----). (B) Generation of hepatocyte-like cells from fibroblast-derived 
undifferentiated iPS cells, as described(41). SFRPs 1 and 2 are shown in human 
foreskin fibroblasts; foreskin fibroblast-derived iPS cells; iPS cells undergoing 
hepatocyte differentiation; human fetal liver and primary human hepatocytes. (C) 
Immunodetection of albumin (ALB), alpha smooth muscle actin (ACTA2), collagen 
type IV (COL4A1) and laminin ɣ1 (LAMC1). Red, FluoProbes 594; green, FITC; 
orange, TRITC; blue, DAPI (nuclei). Liver progenitors incubated with Wnt3a (200 
ng/ml; for 13 days) show few cells containing albumin (white arrow). Instead, they 
differentiate into spindle ACTA2 (+) cells which develop stress fibers typical of 
myofibroblasts (white arrows). The extracellular matrix surrounding these cells 
contains COL4A1 and LAMC1 (white arrows). Control cells receiving control medium 
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(BSA) develop a hepatocyte-like, albumin (+) phenotype. Images were acquired with 
a Cellomics station at 20X. (D) Relative RNA expression of the indicated genes in 
HepaRG liver progenitor cells incubated with control medium (BSA) versus 200 ng/ml 
Wnt3a.  
 
Fig. 5. Bidirectional epithelial-mesenchymal cancer cell plasticity modulates the 
expression of Wnt pathway components, cancer stem cell and myofibroblast 
marker genes.  
(A) Kinetics of mRNA expression of the indicated genes along the differentiation of 
HepaRG progenitors into hepatocyte-like cells. HepaRG liver progenitors were plated 
at 1x104 cells/cm2 and incubated during 30 days, as described(38). Samples 
harvested at day 4 were used as calibrators. Histograms show mean±SD from 
triplicates. SFRP5 is not shown here because it is hardly detected in HepaRG cells 
(Ct>33, Supplementary Fig. 3B). (B and C) 3P/3SP model of spontaneous epithelial 
to mesenchymal transition (EMT) in human HCC(46). Both cell lines are derived from 
the same HCC, mesenchymal 3SP arose from 3P cells through EMT. (B) Hierarchical 
clustering of publically available (GSE26391) whole genome mRNA data from 3P and 
3SP cell lines (at early and late passages). Genes of interest are indicated. (C) 
Unsupervised Gene Set Enrichment Analysis (GSEA) of the GSE26391 mRNA set 
shows that 3SP cells are enriched in Wnt pathway, stem cell and extracellular matrix 
remodeling signatures. The top 20% signatures matching the 3SP transcriptome are 
shown in Supplementary Table 4.  
 
Fig. 6. A network involving cell surface Wnt pathway components, basement 
membrane gene expression and myofibroblast activation in severe liver 
30 
 
fibrosis and HCCs with high tumor fibrosis. Weighted Correlation Network 
Analysis (WGCNA)(27) of mRNA expression data from the indicated patient groups. 
Networks with a correlation coefficient threshold >0.30 were visually integrated with 
Cytoscape(29). Closeness between nodes is proportional to the number of 
connections. Thickness of links is proportional to the correlation coefficients between 
genes. Correlation coefficients are shown in Supplementary Table 5A.  
 
Fig. 7. A minimal signature is associated with lower survival rates and ominous 
clinical features in patients with HCC. A minimal signature (DKK1; COL4A1; 
SFRP1 and LAMC1) was generated by the random survival forest (RSF) method 
from a public mRNA expression dataset (GSE14520) with clinical annotations 
(Supplementary Table 6) from 247 patients with HCC treated by surgical resection 
(55). This signature was used to generate a recurrence risk index (RI; range, 17-132) 
for each individual. Using the centile 0.75 of this index (RI=62), we split the 247-
patient dataset in high (RI>62) and low (RI<62) risk groups. Kaplan-Meier curves and 
Log-Rank tests show significantly different (A) Disease-free and (B) overall survival 
rates. (C and D) Differential clinical features of patients with high and low RI. Age is 
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